300 likes | 490 Views
1. 1. 1. 1. 1. 2. 2. 2. 2. 2. 3. 3. 3. 3. 3. 4. 4. 4. 4. 4. 5. 5. 5. 5. 5. Heart Failure Jeopardy. Volume Mgt. Patient Eval. Drugs. Self-Care . Misc. Three evidence-based beta-adrenergic blockers used to treat systolic heart failure.
E N D
1 1 1 1 1 2 2 2 2 2 3 3 3 3 3 4 4 4 4 4 5 5 5 5 5 Heart Failure Jeopardy Volume Mgt Patient Eval Drugs Self-Care Misc
Three evidence-based beta-adrenergic blockers used to treat systolic heart failure
Medication used in systolic heart failure that decreases morbidity, not mortality (and often added in after use of ACE-inhibitor & beta-blocker
The only major class of drug for which the dose is increased, rather than decreased, in chronic kidney disease
Adherence rate with standard heart failure medications that is associated with better survival
Percentage of sodium in daily diet that comes from adding salt to food
The BMI associated with best survival in heart failure patients
Drug with the shortest half-life: bumetanide, furosemide, torsemide
Weight increases by this # of pounds for each quart of extra fluid in the circulation
This body position affects neurohormonal activation in heart failure and can decrease natriuresis by 30-50%
The single most useful diagnostic test in the evaluation ofpatients with heart failure
Peptide secreted by the ventricles of the heart in response to excessive stretching of heart muscle cells
Three indicators for potential referral for heart failure advanced therapies
Dosing of IV loop diuretic in the urgent/emergent care setting
Most recent published overall U.S. 30-day HF rehospitalization rate
Indication for an Internal Cardioverter Defibrillator in a patient with heart failure
50% of patients diagnosed with heart failure will die in how many years?